[{"id":"592759fa-15ae-4b9c-8238-0dda975b7c5e","acronym":"","url":"https://clinicaltrials.gov/study/NCT04980690","created_at":"2021-07-28T19:52:34.744Z","updated_at":"2024-07-02T16:35:53.531Z","phase":"Phase 1/2","brief_title":"Clinical Trial of IBC0966 in Patients With Advanced Malignant Tumors","source_id_and_acronym":"NCT04980690","lead_sponsor":"SUNHO（China）BioPharmaceutical CO., Ltd.","biomarkers":" HER-2 • PD-L1 • ER • PGR","pipe":" | ","alterations":" PD-L1 expression","tags":["HER-2 • PD-L1 • ER • PGR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PD-L1 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e IBC0966"],"overall_status":"Recruiting","enrollment":" Enrollment 228","initiation":"Initiation: 08/31/2021","start_date":" 08/31/2021","primary_txt":" Primary completion: 12/01/2024","primary_completion_date":" 12/01/2024","study_txt":" Completion: 12/01/2025","study_completion_date":" 12/01/2025","last_update_posted":"2023-03-10"}]